Table 2.
Participant and data characteristics
| Patient interviews | N = 26 |
| Age | |
| Median years (range) | 62 (42–75) |
| Sex | |
| Females/males | 14/12 |
| Index of multiple deprivation decilea | |
| Most deprived (1–3) | 4 |
| Average deprivation (4–7) | 11 |
| Least deprived (8–10) | 8 |
| Format of interview | |
| Telephone | 26 |
| Duration of interview | |
| Median minutes (range) | 61 (40–84) |
| PETReA trial participation status | |
| Consent (v declined) | 25 (v 1) |
| PET-CT response to induction and trial arm allocationb | n = 25 |
| Complete metabolic response (CR) | |
| No further treatment | 9 |
| Maintenance | 8 |
| Partial response (PR) | |
| Maintenance | 4 |
| Maintenance plus Lenalidomide | 4 |
| No. of participating UK sites | 12 |
| Practitioner interviews | N = 15 |
| Practitioner’s role | |
| Haematologist oncologist | 10 |
| Research nurses/clinical trial practitionersc | 5 |
| Format of interview | |
| Telephone | 11 |
| Face-to-face | 3 |
| Video call | 1 |
| Duration of interview | |
| Median minutes (range) | 62 (32–81) |
| No. of participating UK sites | 12 |
| Total interviews | 41 |
| No. of participating UK sites | 16 |
aThe Index of Multiple Deprivation (IMD) deciles were available only for those patients living in mainland England (n=23/26). IMD ranks every small area in England from 1 (most deprived area) to 32,844 (least deprived area). The deciles are derived from the ranks and we divided these into most deprived (1–3), average deprivation (4–7), and least deprived (8–10). bTrial participants only. cClinical trials practitioner is a reasonably new role in the NHS, which entails trial recruitment, education, support and monitoring of the patient entering a clinical trial